Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Keratosis, Actinic 22Brain Neoplasms 10Glioma 7Glioblastoma 7Carcinoma, Basal Cell 4Precancerous Conditions 2Mycosis Fungoides 2Mouth Neoplasms 2Meningioma 2Lymphoma, T-Cell, Cutaneous 2Gliosarcoma 2Basal Cell Nevus Syndrome 2Urinary Bladder Neoplasms 1Squamous Intraepithelial Lesions 1Skull Base Neoplasms 1Skin Neoplasms 1Sezary Syndrome 1Pituitary Neoplasms 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Nonmelanoma Skin Cancers 1Neurofibromatoses 1Neoplasms 1Nasopharyngeal Neoplasms 1Lymphoma 1Leukoplakia 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Rituximab 193Cyclophosphamide 177fludarabine phosphate 151Peripheral Blood Stem Cell Transplantation 89fludarabine 77Mycophenolic Acid 70Filgrastim 63Whole-Body Irradiation 59Tacrolimus 55Lenalidomide 54Cyclosporine 54ibrutinib 53Bendamustine Hydrochloride 50Busulfan 49Melphalan 45Radiotherapy 42Etoposide 42Alemtuzumab 42Antilymphocyte Serum 40ofatumumab 35obinutuzumab 33Methotrexate 33venetoclax 27Cytarabine 25sargramostim 23Granulocyte Colony-Stimulating Factor 22Dexamethasone 21Methylprednisolone 19Bortezomib 19Chlorambucil 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Lymphocytic, Chronic, B-Cell × Aminolevulinic Acid × Clear all
NCT00054171 2013-01-31

Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia

Roswell Park Cancer Institute

Phase 2 Completed
1 enrolled
DermatologicLymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡